Discovery of a novel potent GABAB receptor agonist
摘要:
Structure-activity studies have led to a discovery of 3-(4-pyridyl)methyl ether derivative 9d that has 25- to 50-fold greater functional potency than R-baclofen at human and rodent GABA(B) receptors in vitro. Mouse hypothermia studies confirm that this compound crosses the blood-brain barrier and is approximately 50-fold more potent after systemic administration. (C) 2011 Elsevier Ltd. All rights reserved.
GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAB RECEPTOR LIGANDS
申请人:Xu Feng
公开号:US20100267676A1
公开(公告)日:2010-10-21
Gamma-amino-butyric acid derivatives that are GABA
B
receptor ligands, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives and pharmaceutical compositions thereof for treating diseases are disclosed.
GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAb RECEPTOR LIGANDS
申请人:XenoPort, Inc.
公开号:EP2419401A2
公开(公告)日:2012-02-22
US8344028B2
申请人:——
公开号:US8344028B2
公开(公告)日:2013-01-01
[EN] GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAB RECEPTOR LIGANDS<br/>[FR] DÉRIVÉS D'ACIDE GAMMA-AMINOBUTYRIQUE COMME LIGANDS DES RÉCEPTEURS GABAB
申请人:XENOPORT INC
公开号:WO2010120370A2
公开(公告)日:2010-10-21
Gamma-amino-butyric acid derivatives of formula (I) that are GABAB receptor ligands, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives and pharmaceutical compositions thereof for treating diseases are disclosed. R5 is chosen from -COOH, -SOOH, and -P(O)(OH)R8 wherein R8 is chosen from hydrogen and C1-4 alkyl.
Discovery of a novel potent GABAB receptor agonist
作者:Feng Xu、Ge Peng、Thu Phan、Usha Dilip、Jian Lu Chen、Tania Chernov-Rogan、Xuexiang Zhang、Kent Grindstaff、Thamil Annamalai、Kerry Koller、Mark A. Gallop、David J. Wustrow
DOI:10.1016/j.bmcl.2011.08.006
日期:2011.11
Structure-activity studies have led to a discovery of 3-(4-pyridyl)methyl ether derivative 9d that has 25- to 50-fold greater functional potency than R-baclofen at human and rodent GABA(B) receptors in vitro. Mouse hypothermia studies confirm that this compound crosses the blood-brain barrier and is approximately 50-fold more potent after systemic administration. (C) 2011 Elsevier Ltd. All rights reserved.